122 related articles for article (PubMed ID: 38869944)
1. Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection.
Hoeggerl AD; Nunhofer V; Weidner L; Lauth W; Zimmermann G; Badstuber N; Grabmer C; Kartal O; Jungbauer C; Neureiter H; Held N; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
Infect Dis (Lond); 2024 Jun; ():1-11. PubMed ID: 38869944
[TBL] [Abstract][Full Text] [Related]
2. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
[TBL] [Abstract][Full Text] [Related]
3. Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.
Prete CA; Buss LF; Buccheri R; Abrahim CMM; Salomon T; Crispim MAE; Oikawa MK; Grebe E; da Costa AG; Fraiji NA; do P S S Carvalho M; Whittaker C; Alexander N; Faria NR; Dye C; Nascimento VH; Busch MP; Sabino EC
BMC Infect Dis; 2022 Feb; 22(1):127. PubMed ID: 35123418
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
5. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
6. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
[TBL] [Abstract][Full Text] [Related]
8. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 reinfections in Mexico City: implications for public health.
de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
[TBL] [Abstract][Full Text] [Related]
10. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
[TBL] [Abstract][Full Text] [Related]
11. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing Antibodies against SARS-CoV-2: Importance of Comorbidities in Health Personnel against Reinfections.
Vargas-De-León C; Cureño-Díaz MA; Salazar MI; Cruz-Cruz C; Loyola-Cruz MÁ; Durán-Manuel EM; Zamora-Pacheco ER; Bravata-Alcántara JC; Lugo-Zamudio GE; Fernández-Sánchez V; Bello-López JM; Ibáñez-Cervantes G
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140595
[TBL] [Abstract][Full Text] [Related]
15. Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19.
Peghin M; De Martino M; Palese A; Chiappinotto S; Fonda F; Gerussi V; Sartor A; Curcio F; Grossi PA; Isola M; Tascini C
Clin Microbiol Infect; 2024 Apr; 30(4):522-530. PubMed ID: 38141821
[TBL] [Abstract][Full Text] [Related]
16. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
[TBL] [Abstract][Full Text] [Related]
17. Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Cohen D; Izak M; Stoyanov E; Mandelboim M; Perlman S; Amir Y; Goren S; Bialik A; Kliker L; Atari N; Yshai R; Zaide Y; Marcus H; Madar-Balakirski N; Israely T; Paran N; Zimhony O; Shinar E; Maor Y; Muhsen K
Int J Infect Dis; 2023 Jul; 132():72-79. PubMed ID: 37072052
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
[TBL] [Abstract][Full Text] [Related]
19. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
Peghin M; Bouza E; Fabris M; De Martino M; Palese A; Bontempo G; Graziano E; Gerussi V; Bressan V; Sartor A; Isola M; Tascini C; Curcio F
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2597-2604. PubMed ID: 34378086
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in City Council Civil Servants, 1 March 2020-31 January 2023: Risk of Infection, Reinfection, Vaccine Effectiveness and the Impact of Heterologous Triple Vaccination.
Cegolon L; Larese Filon F
Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543888
[No Abstract] [Full Text] [Related]
[Next] [New Search]
